Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 698 of 767

Advanced search

🇺🇸Jan 8Researchpodcasters.spotify.comTier 3 · Secondary coverage

The long game of American reindustrialization

Lux CapitalOriginal source

🇺🇸Jan 8Researcharchventure.comTier 2 · Direct publisher

D-Wave Quantum acquires ARCH-backed Quantum Circuits to accelerate the development of quantum computers

ARCH Venture PartnersOriginal source

🌍Jan 7Industryoramed.comTier 1 · Company source

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

Oramed PharmaceuticalsOriginal source

🌍Jan 7Mediascience37.comTier 2 · Direct publisher

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards

Science 37Original source

🇺🇸Jan 7Industryneogenomics.comTier 1 · Company source

Partners in cancer care

NeoGenomicsOriginal source

🌍Jan 6Medialemsurgical.comTier 2 · Direct publisher

LEM Surgical Showcased in NVIDIA CES 2026 Keynote

LEM Surgical (Dynamis Spine Robot)Original source

🌍Jan 6Industrynimbustx.comTier 1 · Company source

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

Nimbus TherapeuticsOriginal source

🇫🇷Jan 6Industrypierre-fabre.comTier 1 · Company source

Pierre Fabre, un modèle d'excellence en actionnariat salarié

Pierre FabreOriginal source

🌍Jan 6Industryabelzeta.comTier 1 · Company source

AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion

AbelZeta PharmaOriginal source

🇺🇸Jan 6CROinvestor.medpace.comTier 2 · Direct publisher

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

MedpaceOriginal source

🌍Jan 5Mediaperspectum.comTier 2 · Direct publisher

Perspectum Announces Executive Leadership Changes

PerspectumOriginal source

🌍Jan 5Mediaperspectum.comTier 2 · Direct publisher

Perspectum and Avant Santé announce strategic partnership to strengthen quantitative imaging for metabolic and liver research in Mexico and Latin America

PerspectumOriginal source

🌍Jan 5Industryskyebioscience.comTier 1 · Company source

Working with Halozyme ENHANZE® Technology for Higher Dosing

Skye BioscienceOriginal source

🌍Jan 5Industryskyebioscience.comTier 1 · Company source

Using Arecor’s Arestat Technology to Increase Drug Dosing

Skye BioscienceOriginal source

🌍Jan 5Industryskyebioscience.comTier 1 · Company source

Unlocking Solutions to Deliver Higher Doses

Skye BioscienceOriginal source

🇯🇵Jan 5Researchmed.kyoto-u.ac.jpTier 2 · Direct publisher

Prof. Akiyuki Taruno has taken up his post in the Cellular and Molecular Physiology

Kyoto University Faculty of MedicineOriginal source

🇯🇵Jan 5Devicesolympus-global.comTier 1 · Company source

Olympus to Present at J.P. Morgan Healthcare Conference

Olympus MedicalOriginal source

🌍Jan 5Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026

GH ResearchOriginal source

🇺🇸Jan 2Researchmdanderson.orgTier 2 · Direct publisher

Exercise snacks: How to sneak more exercise in your day

MD Anderson Cancer CenterOriginal source

🌍Jan 2Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research to Announce IND Status for GH001

GH ResearchOriginal source

🌍Jan 1Industryevidana.comTier 1 · Company source

Elevate Your Dining Experience with Eco-Friendly Plates and Bowls

EvidanaOriginal source

🇮🇱Dec 31Researchaionlabs.comTier 2 · Direct publisher

Summarizing Pharma-Biotech Deals 2025

AION Labs - Pfizer, Merck, Teva Joint VentureOriginal source

🌍Dec 31Industryinvestors.xoma.comTier 1 · Company source

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

Xoma CorporationOriginal source

🌍Dec 24Industryskyebioscience.comTier 1 · Company source

CEO 2025 Year in Review

Skye BioscienceOriginal source

🇺🇸Dec 22Industryclinicalink.comTier 1 · Company source

Clinical ink announces collaboration with Tandem Diabetes Care to integrate Automated Insulin Delivery data into the GlucoseReady™ connected device software platform

Clinical InkOriginal source

🇺🇸Dec 22Researchpodcasters.spotify.comTier 3 · Secondary coverage

11 Clips That Defined 2025

Lux CapitalOriginal source

🇸🇬Dec 22Researchscri.edu.sgTier 2 · Direct publisher

Clinical Research Coordinator Onboarding Programme (October 2025 Intake)

Singapore Clinical Research InstituteOriginal source

🌍Dec 20Industryaptose.comTier 1 · Company source

Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC

Aptose BiosciencesOriginal source

🌍Dec 19Industrynimbustx.comTier 1 · Company source

Nimbus Therapeutics Announces Completion of Dose Escalation in Phase 1/2 Clinical Trial of NDI-219216, Novel WRN Inhibitor for MSI-H Tumors

Nimbus TherapeuticsOriginal source

🌍Dec 19Industrymyriad.comTier 3 · Secondary coverage

Tyrer-Cuzick and the MyRisk Hereditary Cancer Test® with RiskScore®: Risk Assessment Tools for a Smarter, Personalized Approach to Breast Cancer Screening

MyriadOriginal source

🇫🇷Dec 18Industrypierre-fabre.comTier 1 · Company source

Meilleurs voeux 2026

Pierre FabreOriginal source

🇨🇭Dec 18Industryatinary.comTier 1 · Company source

Atinary and SwissCAT+ Showcase the Future of Materials Discovery

Atinary TechnologiesOriginal source

🌍Dec 18Industryintercure.coTier 1 · Company source

Bazelet group has initiated restructuring proceedings before the Israeli District Court, including an application for a temporary stay of proceedings

InterCureOriginal source

🇺🇸Dec 18Industryvikingtherapeutics.comTier 1 · Company source

Matthew Singleton - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Dec 18Industryvikingtherapeutics.comTier 1 · Company source

Charles A. Rowland Jr. - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Dec 18Industryvikingtherapeutics.comTier 1 · Company source

Kathy Rouan, Ph.D. - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Dec 18Industryvikingtherapeutics.comTier 1 · Company source

Matthew W. Foehr - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Dec 18Researchpodcasters.spotify.comTier 3 · Secondary coverage

Can software platforms reverse enshittification?

Lux CapitalOriginal source

🇺🇸Dec 18Industryvikingtherapeutics.comTier 1 · Company source

Brian Lian, Ph.D. - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Dec 18Industryvikingtherapeutics.comTier 1 · Company source

Geoffrey Barker, Ph.D. - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Dec 17Industrybrukercellularanalysis.comTier 3 · Secondary coverage

University of Texas at Arlington’s IMPRINT Ushers in a New Era with Beacon Discovery

Berkeley LightsOriginal source

🇺🇸Dec 17Researchforesitecapital.comTier 2 · Direct publisher

Q&A with Foresight Diagnostics on their acquisition by Natera

Foresite CapitalOriginal source

🌍Dec 16Mediaseqens.comTier 2 · Direct publisher

Brenntag and SEQENS partner for the commercialization of non-GMP pharmaceutical intermediates in Europe

SeqensOriginal source

🌍Dec 16Medianorstella.comTier 2 · Trade media